There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐
stage renal disease patients undergoing dialysis. This review aimed to summarize the …

Chronic kidney disease (CKD) is defined by persistent urine abnormalities, structural
abnormalities or impaired excretory renal function suggestive of a loss of functional …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Acute kidney disease (AKD)-which includes acute kidney injury (AKI)–and chronic kidney
disease (CKD) are highly prevalent among hospitalized patients, including those in …

Objective To better define the prevalence of protein-energy wasting (PEW) in kidney disease
is poorly defined. Methods We performed a meta-analysis of PEW prevalence from …

Abstract Objectives of Review: Protein-energy wasting (PEW) is a state of disordered
catabolism resulting from metabolic and nutritional derangements in chronic disease states …

Loss of muscle proteins is a deleterious consequence of chronic kidney disease (CKD) that
causes a decrease in muscle strength and function, and can lead to a reduction in quality of …

Hemodialysis (HD) majorly represents the global treatment option for patients with chronic
kidney disease stage 5, and, despite advances in dialysis technology, these patients face a …

Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for nutrition in kidney diseases since …

In patients with chronic kidney disease (CKD), loss of cellular proteins increases the risks of
morbidity and mortality. Persistence of muscle protein catabolism in CKD results in striking …